JPWO2025005305A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2025005305A5
JPWO2025005305A5 JP2025515644A JP2025515644A JPWO2025005305A5 JP WO2025005305 A5 JPWO2025005305 A5 JP WO2025005305A5 JP 2025515644 A JP2025515644 A JP 2025515644A JP 2025515644 A JP2025515644 A JP 2025515644A JP WO2025005305 A5 JPWO2025005305 A5 JP WO2025005305A5
Authority
JP
Japan
Prior art keywords
cellulose
formulation according
starch
sodium
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2025515644A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2025005305A1 (https=
JP7701585B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2024/035558 external-priority patent/WO2025005305A1/ja
Publication of JPWO2025005305A1 publication Critical patent/JPWO2025005305A1/ja
Publication of JPWO2025005305A5 publication Critical patent/JPWO2025005305A5/ja
Application granted granted Critical
Publication of JP7701585B2 publication Critical patent/JP7701585B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2025515644A 2023-10-05 2024-10-04 ウラシル誘導体を含有する製剤 Active JP7701585B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2023173297 2023-10-05
JP2023173297 2023-10-05
JP2024088082 2024-05-30
JP2024088082 2024-05-30
PCT/JP2024/035558 WO2025005305A1 (ja) 2023-10-05 2024-10-04 ウラシル誘導体を含有する製剤

Publications (3)

Publication Number Publication Date
JPWO2025005305A1 JPWO2025005305A1 (https=) 2025-01-02
JPWO2025005305A5 true JPWO2025005305A5 (https=) 2025-06-04
JP7701585B2 JP7701585B2 (ja) 2025-07-01

Family

ID=93938364

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2025515644A Active JP7701585B2 (ja) 2023-10-05 2024-10-04 ウラシル誘導体を含有する製剤

Country Status (4)

Country Link
JP (1) JP7701585B2 (https=)
AU (1) AU2024309726A1 (https=)
TW (1) TW202523308A (https=)
WO (1) WO2025005305A1 (https=)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH12021552872A1 (en) 2020-04-05 2022-03-21 Pfizer Compounds and methods for the treatment of covid-19
US11351149B2 (en) 2020-09-03 2022-06-07 Pfizer Inc. Nitrile-containing antiviral compounds
LT4122926T (lt) 2021-04-14 2025-07-25 Shionogi & Co., Ltd. Triazino dariniai, turintys virusų replikaciją slopinantį poveikį, ir juos apimanti farmacinė kompozicija
JP7624093B2 (ja) 2022-04-08 2025-01-29 塩野義製薬株式会社 ウイルス増殖阻害活性を有するウラシル誘導体およびそれらを含有する医薬組成物

Similar Documents

Publication Publication Date Title
JP5557146B2 (ja) 難溶性薬物の溶解性改善製剤
US7550153B2 (en) Pantoprazole multiparticulate formulations
AU2004305226A1 (en) Method for the production of a solid, orally applicable pharmaceutical composition
US20150209432A1 (en) Pharmaceutical compositions of proton pump inhibitor
JP7750956B2 (ja) 安定性及び生体利用効率が改善されたオラパリブ固体分散体組成物
TWI883162B (zh) 一種非布司他片
EP3796908B1 (en) Controlled release propiverine formulations
JPWO2025005305A5 (https=)
CA3227178A1 (en) Desidustat particles and compositions thereof
WO2022153330A1 (en) Pharmaceutical compositions comprising acalabrutinib
WO2020104955A1 (en) Pharmaceutical compositions of acotiamide and proton pump inhibitor
JP6903252B2 (ja) キサンチンオキシダーゼ阻害剤含有腸溶性製剤
WO2025164725A1 (ja) ジヒドロピリジノン誘導体を含有する医薬組成物
US10034855B2 (en) Solid composition of pyrrole carboxamide
KR20250123715A (ko) 생체이용률이 개선된 닌테다닙을 포함하는 약학적 조성물
HK40104153A (zh) 德度司他颗粒及其组合物
WO2019209208A2 (en) Controlled-release pharmaceutical compositions of ivabradine
WO2010123440A1 (en) Pharmaceutical composition comprising 4-amino-8-(2-fluoro-6-methoxy-phenyl)-n- propylcinnoline-3-carboxamide hydrogen sulphate and rate-controlling polymer
HK1082909A1 (en) Controlled-release drug composition
HK1082909B (en) Controlled-release drug composition